April 21, 2022 (Earnings Report)Dear Reader,We just identified several healthtech stocks that are expected to release earnings this week.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Danaher
Symbol: DHR
Recent Price: $280.38
Average Analyst Price Target: $332.14 (18.46%)
Market Cap: $200.72B
Last Year's EPS: $2.52
Consensus EPS Forecast: $2.67
Expected Earnings Date: Apr 20 2022
Recent Analyst Action: Luke Sergott, analyst at Barclays, reiterates coverage on Danaher (DHR) in the Healthcare sector with a Buy rating and a price target of $ 320 (1 day ago).
TipRanks.com also reports that Danaher currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $332.14 . The target pricing ranges from a high forecast of $360.00 down to a low forecast of $311.00. Danaher (DHR)’s last closing price was $280.38 which would put the average price target at 18.46% upside.Here are 3rd party ratings for DHR:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Buy, Top 26% (66 out of 253)
--------------------------------------------------------------------------
Intuitive Surgical
Symbol: ISRG
Recent Price: $302.9
Average Analyst Price Target: $330.11 (8.98%)
Market Cap: $108.80B
Last Year's EPS: $1.17
Consensus EPS Forecast: $1.08
Expected Earnings Date: Apr 20 2022
Recent Analyst Action: Imron Zafar, analyst at Deutsche Bank, reiterates coverage on Intuitive Surgical (ISRG) in the Healthcare sector with a Hold rating and a price target of n/a (1 week ago).
TipRanks.com also reports that Intuitive Surgical currently has 20 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $330.11 . The target pricing ranges from a high forecast of $370.00 down to a low forecast of $230.00. Intuitive Surgical (ISRG)’s last closing price was $302.9 which would put the average price target at 8.98% upside.Here are 3rd party ratings for ISRG:
- TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 35% (165 out of 253)
--------------------------------------------------------------------------
Plus Therapeutics
Symbol: PSTV
Recent Price: $0.872
Average Analyst Price Target: $7.00 (702.75%)
Market Cap: $19.34M
Last Year's EPS: -$0.33
Consensus EPS Forecast: -$0.2
Expected Earnings Date: Apr 20 2022
Recent Analyst Action: Sean Lee, analyst at H.C. Wainwright, reiterates coverage on Plus Therapeutics (PSTV) in the Healthcare sector with a Buy rating and a price target of $ 7 (1 month ago).
TipRanks.com also reports that Plus Therapeutics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $7.00 . The target pricing ranges from a high forecast of $7.00 down to a low forecast of $7.00. Plus Therapeutics (PSTV)’s last closing price was $0.872 which would put the average price target at 702.75% upside.Here are 3rd party ratings for PSTV:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Top 42% (106 out of 253)
--------------------------------------------------------------------------
Quest Diagnostics
Symbol: DGX
Recent Price: $138.45
Average Analyst Price Target: $149.44 (7.94%)
Market Cap: $16.31B
Last Year's EPS: $3.76
Consensus EPS Forecast: $2.99
Expected Earnings Date: Apr 20 2022
Recent Analyst Action: Patrick B, analyst at Citigroup, reiterates coverage on Quest Diagnostics (DGX) in the Healthcare sector with a Hold rating and a price target of n/a (2 weeks ago).
TipRanks.com also reports that Quest Diagnostics currently has 10 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $149.44 . The target pricing ranges from a high forecast of $185.00 down to a low forecast of $129.00. Quest Diagnostics (DGX)’s last closing price was $138.45 which would put the average price target at 7.94% upside.Here are 3rd party ratings for DGX:
- TipRanks.com: Hold
- TradingView.com: Neutral
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 21% (200 out of 253)
--------------------------------------------------------------------------
Arjo AB
Symbol: ARRJF
Recent Price: $7.94
Average Analyst Price Target: $10.84 (36.52%)
Market Cap: $2.16B
Last Year's EPS: $0.07
Consensus EPS Forecast: $0.06
Expected Earnings Date: Apr 21 2022
Recent Analyst Action: Karl Noren, analyst at Danske Bank, reiterates coverage on Arjo AB (ARRJF) in the Healthcare sector with a Hold rating and a price target of $ 8.92 (2 weeks ago).
TipRanks.com also reports that Arjo AB currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.84 . The target pricing ranges from a high forecast of $12.59 down to a low forecast of $8.92. Arjo AB (ARRJF)’s last closing price was $7.94 which would put the average price target at 36.52% upside.Here are 3rd party ratings for ARRJF:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: n/a
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
HCA Healthcare
Symbol: HCA
Recent Price: $275.16
Average Analyst Price Target: $279.30 (1.50%)
Market Cap: $83.10B
Last Year's EPS: $4.14
Consensus EPS Forecast: $4.25
Expected Earnings Date: Apr 21 2022
Recent Analyst Action: Whit Mayo, analyst at Leerink Partners, reiterates coverage on HCA Healthcare (HCA) in the Healthcare sector with a Buy rating and a price target of $ 304 (2 weeks ago).
TipRanks.com also reports that HCA Healthcare currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $279.30 . The target pricing ranges from a high forecast of $304.00 down to a low forecast of $250.00. HCA Healthcare (HCA)’s last closing price was $275.16 which would put the average price target at 1.50% upside.Here are 3rd party ratings for HCA:
- TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 42% (107 out of 253)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com
